The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...

Diffuse Large B-Cell Lymphoma Companies are involved in targeted therapeutics development with respective active and inactive ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood ...

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

From left to right: Prof Chuxia Deng, Chair Professor and Dean of the Faculty of Health Sciences; Prof Chen Xin, Distinguished Professor and Director of the Institute of Chinese Medical Sciences; Prof ...